Compare LENZ & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LENZ | QTRX |
|---|---|---|
| Founded | 2019 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.5M | 160.0M |
| IPO Year | 2021 | 2017 |
| Metric | LENZ | QTRX |
|---|---|---|
| Price | $4.58 | $3.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $44.00 | $6.00 |
| AVG Volume (30 Days) | ★ 817.7K | 791.6K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $19,088,000.00 | ★ $37,632,000.00 |
| Revenue This Year | $50.42 | $25.49 |
| Revenue Next Year | $197.16 | $10.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $4.54 | $2.15 |
| 52 Week High | $50.19 | $8.77 |
| Indicator | LENZ | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.98 | 47.56 |
| Support Level | N/A | $3.10 |
| Resistance Level | $6.18 | $3.85 |
| Average True Range (ATR) | 0.41 | 0.28 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 2.49 | 52.71 |
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.